1-[2-(1H-imidazol-1-yl)phenyl]ethanone | 20513-61-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-[2-(1H-imidazol-1-yl)phenyl]ethanone
• 英文别名: 1-(2-imidazol-1-ylphenyl)ethanone
• CAS: 20513-61-5
• 化学式: C₁₁H₁₀N₂O
• mdl: MFCD00127221
• 分子量: 186.21
• InChiKey: CUBZSVCEOTUDGR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  34.9
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[2-(1H-imidazol-1-yl)phenyl]ethanone 生成 2-imidazol-1-yl-N-methyl-1-phenylethanimine oxide
  参考文献：
  名称：

  GEORGIEV, VASSIL S.;MULLEN, GEORGE B.

  摘要：

  DOI：

文献信息

• 10A-AZALIDE COMPOUND HAVING 4-MEMBERED RING STRUCTURE
  申请人：Sugimoto Tomohiro

  公开号：US20110152239A1

  公开（公告）日：2011-06-23

  The present invention relates to a process for preparing compositions of high concentrations of omega-3 fatty acids from krill. Furthermore, the invention relates to a composition comprising high concentrations of omega-3 fatty acids, and a lipid fraction from krill comprising high amounts of the fatty acids with chain length C14 and C 16.

  本发明涉及一种从磷虾制备高浓度ω-3脂肪酸组合物的方法。此外，本发明涉及一种包含高浓度ω-3脂肪酸的组合物，以及从磷虾中提取的含有链长为C14和C16的脂肪酸高含量的脂质分数。
• INHIBITORS OF MYOCARDIN-RELATED TRANSCRIPTION FACTOR AND SERUM RESPONSE FACTOR (MRTF/SRF)-MEDIATED GENE TRANSCRIPTION AND METHODS FOR USE OF THE SAME
  申请人：THE REGENTS OF THE UNIVERSITY OF MICHIGAN

  公开号：US20160145251A1

  公开（公告）日：2016-05-26

  Disclosed herein are inhibitors of gene transcription mediated by myocardin-related transcription factor and serum response factor, or both myocardin-related transcription factor and serum response factor (“MRTF/SRF”), and methods for their use in treating or preventing cancer and fibrosis. In particular, disclosed herein are compounds of Formula (I) and Formula (II), and pharmaceutically acceptable salts thereof: wherein the substituents are as described.

  本文披露了抑制由肌动蛋白相关转录因子和血清反应因子或肌动蛋白相关转录因子和血清反应因子（“MRTF / SRF”）介导的基因转录的抑制剂，以及它们在治疗或预防癌症和纤维化方面的使用方法。特别地，本文披露了公式（I）和公式（II）的化合物及其药学上可接受的盐：其中取代基如所述。
• US8299035B2
  申请人：——

  公开号：US8299035B2

  公开（公告）日：2012-10-30
• [EN] INHIBITORS OF MYOCARDIN-RELATED TRANSCRIPTION FACTOR AND SERUM RESPONSE FACTOR (MRTF/SRF)-MEDIATED GENE TRANSCRIPTION AND METHODS FOR USE OF THE SAME<br/>[FR] INHIBITEURS DE LA TRANSCRIPTION DE GÈNES MÉDIÉE PAR LE FACTEUR APPARENTÉ À LA MYOCARDINE ET LE FACTEUR DE RÉPONSE SÉRIQUE (MRTF/SRF) ET PROCÉDÉS POUR LES UTILISER
  申请人：UNIV MICHIGAN

  公开号：WO2016073847A2

  公开（公告）日：2016-05-12

  Disclosed herein are inhibitors of gene transcription mediated by myocardin-related transcription factor and serum response factor, or both myocardin-related transcription factor and serum response factor ("MRTF/SRF"), and methods for their use in treating or preventing cancer and fibrosis. In particular, disclosed herein are compounds of Formula (I) and Formula (II), and pharmaceutically acceptable salts thereof: wherein the substituents are as described.